A metaresearch group at Tilburg University in the Netherlands investigates scientists’ research methods and operations, scrutinizing questionable practices such as selective reporting of statistical tests and data massaging. The group instead advocates for practices such as preregistering studies and making experimental data immediately available for open external review and verification. Its members are optimistic that “the perverse incentives of careerist academia, to hoard data and sacrifice rigor for headline-generating findings, will ultimately be fixed.”
What is a kipping pull-up? Isn’t that cheating? A kipping pull-up is a form of pull-up where you swing your body and use the momentum and a hip drive to get your body to the bar. It’s not cheating because it’s not meant to be the same exercise as a dead-hang pull-up. Some workouts call for a dead-hang pull-up – and in those you would not be allowed to kip.
ICYMI: Whole30 is an elimination-style diet that asks dieters to ban all soy, dairy, grains, alcohol, legumes, and added sugars from their diet for 30 days straight. The point is to flush your system, so when the 30 days are up, you can slowly add different food groups back and get a sense of which ones have been secretly affecting your physical and mental health. The creator, Melissa Hartwig, also says Whole30 will change your entire relationship with food.
The Paleo concept is new for most people and this newness can spark many questions. We like people to not only read about and educate themselves on this topic but also to “get in and do it.” Experience is perhaps the best teacher and often cuts through any confusion surrounding this way of eating. Now, all that considered, there are still some common counter arguments to the Paleo diet that happen with sufficient frequency that a whole paper was written on it. Enjoy: Evolutionary Health Promotion. A consideration of common counter-arguments.

The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”